MedDataX Logo

Suprascapular Neuropathy in the Setting of Rotator Cuff Tears: Results of Arthroscopic Treatment

NCT02318381 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2018-12-27

No results posted yet for this study

Summary

Aim of this prospective double blind randomized clinical trial is to understand the correlation of suprascapular neuropathy in the setting of large and massive tears of the shoulder rotator cuff and to investigate whether arthroscopic dissection of the superior transverse scapular ligament is positively related to the improvement of this neuropathy.

Conditions

  • Entrapment Neuropathy
  • Rotator Cuff Tear

Interventions

PROCEDURE

Dissection of the superior transverse scapular ligament

After treatment of the rotator cuff tear, the arthroscopic procedure will also proceed with the dissection of the superior transverse scapular ligament, in order to release pressure from the suprascapular nerve.

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    lead OTHER

Principal Investigators

  • Nikolaos P Sachinis, M.D. · First Orthopaedic Department of Aristotle University of Thessaloniki

  • Pericles Papadopoulos, Ph.D. · First Orthopaedic Department of Aristotle University of Thessaloniki

  • Sotirios Papagianopoulos, Ph.D. · Τhird Neurology Department of Aristotle University of Thessaloniki

  • Ioannis Sarris, Ph.D. · Third Orthopaedic Department of Aristotle University of Thessaloniki

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2018-05-31
Completion
2018-09-30

Countries

  • Greece

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02318381 on ClinicalTrials.gov